Biography
Prof Emily Callander is a health economist and health services researcher specialising in maternal, women’s and child health. Emily is a Professor, and Head of Discipline for Health Services Management in the School of Public Health. She leads a Women’s Economics and Value-Based Care research program, externally funded by a number of NHMRC and MRFF grants, which collaborates widely to provide the economic evidence base to guide health service and policy decision-making. This includes undertaking economic evaluation alongside randomised controlled trials, measuring costs and outcomes with real-world linked administrative data, and conducting local-health service level economic modelling. Emily sits on a number of maternal health state government committees; and is a member of the Pharmaceutical Benefits Advisory Committee Economics Subcommittee. Her mission is to improve the equity and efficiency of health services and systems by embedding economic evidence into decision-making.
Abstract
There is a vast volume of data collected as a part of day to day delivery of health services. Due to the activity based funding nature of the Australian health care system, these health data also include detailed information on the health services utilised by patients. Such routine administrative data thus provides many benefits for health economic evaluations that require quantification of health service use. This presentation will illustrate the use of routine health service data as a part of two evaluation activities – one a hospital-level service evaluation, and the other a nation-wide implementation program evaluation. It will cover the benefits and challenges associated with use of administrative data, and the practical steps required to access and utilise such data. This talk will be pitched to those who do not have prior experience with use of health administrative data, and it also will not assume health economics expertise.
Latest Resource
-
Approaches to prioritising research
for clinical trial networks: a scoping review -
HEAT Webinar Recording- Economic Evaluation Alongside Adaptive Trials
-
ACTA 2021-2022 Annual Report
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Economic evaluation alongside cluster trial – webinar recording
-
Development of the Consumer Involvement and Engagement Toolkit
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021
-
ACTA 2020-2021 Annual Report
-
ACTA Whistleblower Policy
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
ACTA Year in Review: Financial Year 2019-2020
-
Statistical Analysis Plan (SAP)
-
ACTA Board Charter
-
ACTA Constitution
-
ACTA Trial of the Year Award 2020 guidelines and nomination forms
-
ACTA Year in Review: Financial Year 2018-2019
-
ACTA Resources Brochure
-
ACTA activity work plan 2019 – 2020
-
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
-
What a trialist should know about implementation to practice
-
Submission to MRFF Consultation
-
Submission to Medical Research Future Fund Priority Consultation
-
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
-
ACTA Advisory Council minutes July 2017
-
Economic evaluation of investigator-initiated clinical trials conducted by networks
-
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results
-
Open letter to the Hon Greg Hunt MP following announcement of MRFF funding for ACTA and clinical trials
-
How can clinical trials networks drive better translation of evidence into better quality care?
-
The Global Perspective: Measuring the impact of Australian-led trials & registries internationally
-
ACTA Summit 2016 – Opening address
-
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement
-
ACTA Summit 2016 – Dr Neil Soderlund